| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999021977A9 Recombinational cloning using nucleic acids having recombination sites |
| 07/01/1999 | WO1999020773A3 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
| 07/01/1999 | WO1999020771A3 Multiply-substituted protease variants with altered net charge for use in detergents |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | WO1999020742A3 A packaging cell line producing siv-pseudotyped mlv |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 07/01/1999 | WO1999019493A3 Cytochrome p-450 constructs and methods of producing herbicide-resistant transgenic plants |
| 07/01/1999 | WO1999019491A3 Human dnax interleukin-40 (dil-40) |
| 07/01/1999 | WO1999019470A3 Gfp-annexin fusion proteins |
| 07/01/1999 | WO1999018909A9 Interferon-gamma regulatory factors |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999011292A3 Compositions and methods for treating arthritis utilizing gene therapy |
| 07/01/1999 | WO1999010487A3 Novel transcriptional regulators and uses therefor |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | WO1999006587A3 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
| 07/01/1999 | WO1999002656A8 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 07/01/1999 | DE19901761A1 Oligonucleotides tagged with photoinducible redox-active unit |
| 07/01/1999 | DE19858447A1 Isolating and purifying nucleic acid |
| 07/01/1999 | DE19757984A1 Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung Regulatory DNA sequences from the 5 'region of the gene of human telomerase catalytic subunit UDN their diagnostic and therapeutic use |
| 07/01/1999 | DE19757695A1 Klonierte, Neurotransmitter-Rezeptor produzierende Zellen Cloned, neurotransmitter receptor-producing cells |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | DE19752855A1 Retrovirale Pseudotyp-Vektoren mit modifizierten Oberflächen-Hüllproteinen und Verfahren zu ihrer Herstellung für den selektiven Gentransfer Retroviral vectors pseudotyped with modified surface envelope proteins and methods for their preparation for selective gene transfer |
| 07/01/1999 | DE19752854A1 Cell-specific retroviral vectors with antibody domains suitable for cell-specific transduction of selected mammal cell types |
| 07/01/1999 | DE19752666A1 Preparation of transformed wood |
| 07/01/1999 | CA2318434A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | CA2316769A1 The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase |
| 07/01/1999 | CA2316414A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells |
| 07/01/1999 | CA2316321A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors |
| 07/01/1999 | CA2316081A1 Bacterial nitrite oxidizer and method of use thereof |
| 07/01/1999 | CA2316034A1 Sigirr dna and polypeptides |
| 07/01/1999 | CA2316015A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315943A1 Multiple drug resistance gene atrc of aspergillus nidulans |
| 07/01/1999 | CA2315942A1 Tigirr dna and polypeptides |
| 07/01/1999 | CA2315888A1 Beta-lipotropin and uses thereof |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315301A1 Protein binding polypeptides |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315269A1 Equine infectious anaemia virus (eiav) based |
| 07/01/1999 | CA2315257A1 Method for isolating short and long-chain nucleic acids |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | CA2315240A1 Human proteins responsible for nedd8 activation and conjugation |
| 07/01/1999 | CA2315166A1 Method for reduction of transgene copy number |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | CA2314437A1 Mood disorder gene |
| 07/01/1999 | CA2314357A1 Transgenic animal model for degenerative diseases of cartilage |
| 07/01/1999 | CA2313804A1 Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis |
| 07/01/1999 | CA2311999A1 Genetic inhibition by double-stranded rna |
| 07/01/1999 | CA2311416A1 Prostate cancer gene |
| 07/01/1999 | CA2309391A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 06/30/1999 | EP0926543A1 Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof |
| 06/30/1999 | EP0926241A2 Use of dehydrodiconferyl alcohol glucosyl transferase in the regulation of plant development and defence |
| 06/30/1999 | EP0926240A2 Candida biodinii Formate Dehydrogenase mutants, gene sequences encoding them and use of these Formate Dehydrogenase mutants |
| 06/30/1999 | EP0926239A2 Beta-lipotropin and uses thereof |
| 06/30/1999 | EP0926238A2 Putative Adrenomedullin receptor polypeptide |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926157A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 06/30/1999 | EP0926156A2 Vector comprising Mycobacterium tuberculosis 38 kDa antigen for neoplasm treatment |
| 06/30/1999 | EP0925647A1 Electroporation employing user-configured pulses |
| 06/30/1999 | EP0925554A1 Method and apparatus for analyzing images |
| 06/30/1999 | EP0925367A2 A process of increasing plant growth and yield and modifiying cellulose production in plants |
| 06/30/1999 | EP0925366A1 Methods for producing carotenoid compounds and speciality oils in plant seeds |
| 06/30/1999 | EP0925365A1 Materials and methods for increasing corn seed weight |
| 06/30/1999 | EP0925364A1 A lactic acid bacterial regulatable expression system |
| 06/30/1999 | EP0925363A1 Self-secreting proteases |
| 06/30/1999 | EP0925362A2 Transgenic plants expressing cellulolytic enzymes |
| 06/30/1999 | EP0925361A1 Microorganism, lactamase enzyme obtained therefrom, and their use |
| 06/30/1999 | EP0925360A1 Angiogenic factor and use thereof in treating cardiovascular disease |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925358A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 06/30/1999 | EP0925357A1 Human cns cell lines and methods of use therefor |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0925074A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 06/30/1999 | EP0925073A1 $i(STAPHYLOCOCCUS AUREUS) ANTIGEN |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0924990A1 Frozen food with antifreeze peptides |
| 06/30/1999 | EP0891393B1 Asymmetric benzoxanthene dyes |
| 06/30/1999 | EP0799319A4 Purified thermococcus barossii dna polymerase |
| 06/30/1999 | EP0725141A4 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland |
| 06/30/1999 | EP0701606A4 Method of enhancing thrombolysis |
| 06/30/1999 | CN2326606Y Mechanical-arm gene amplification instrument |
| 06/30/1999 | CN1221492A Method of enriching rare cells |
| 06/30/1999 | CN1221456A 'alpha' 2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same |
| 06/30/1999 | CN1221455A Aspergillus porphobilinogen synthases and nucleic acids encoding same |
| 06/30/1999 | CN1221454A Regulating metabolism by modifying level of trehalose-6-phosphate |
| 06/30/1999 | CN1221453A Method for increasing hemoprotein production in filamentous fungi |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221451A Vaccine containing peroxiredoxin and/or 'beta'-tubulin |
| 06/30/1999 | CN1221450A Spruce bunworm antifreeze proteins, genes and methods of using the same |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221428A Cellular internalization of PIGR large biological molecule characteristic high structure and associated ligands |
| 06/30/1999 | CN1221426A Fragments of leptin (OB protein) |
| 06/30/1999 | CN1221345A Isolated necleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof |